Basket | Login | Register


Bill Gates announces $30 Million investment to support AD research

Tuesday 17 July 2018

Last fall, Microsoft co-founder and billionaire philanthropist Bill Gates announced he was investigating in Alzheimer’s disease (AD) for the first time. On 17 July, he announced his next investment in AD with the launch of the Diagnostics Accelerator - a "venture philanthropy" fund backed by Bill Gates and Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder. They are joined by other philanthropists, including the Dolby family and the Charles and Helen Schwab Foundation. This coalition of philanthropists has committed more than $30 million to accelerate innovative new ideas for earlier and better diagnosis of AD and related dementias. The project is now seeking proposals for funding on the new Diagnostics Accelerator website.

On his personal blog, Gates wrote “My hope is that this investment builds a bridge from academic research to a reliable, affordable, and accessible diagnostic. I expect to see lots of new players come to the table, who have innovative new ideas but might not have previously had the resources to explore them”.